Company: AEMD
Filing Date: 2025-07-25
Form Type: DRS
Source: 0001683168-25-005397
Chunk: 81

Company: AETHLON MEDICAL INC
Filing Date: 2025-07-25
Form: DRS
Chunk 81
---
 ended March 31, 2024 incorporated by reference in this Registration Statement and
Prospectus have been so incorporated in reliance on the report of Baker Tilly US, LLP, an independent registered public accounting firm,
given on the authority of said firm as experts in auditing and accounting.

<div align='center'>MARKET AND INDUSTRY DATA</div>

Unless otherwise indicated,
information contained in this prospectus concerning the medical device industry, including our market opportunity, is based on information
from independent industry analysts, third-party sources and management estimates. Management estimates are derived from publicly available
information released by independent industry analysts and third-party sources, as well as data from our internal research, and are based
on assumptions made by us based on such data and our knowledge of such industry and market, which we believe to be reasonable. In addition,
while we believe the market opportunity information included in this prospectus is generally reliable and is based on reasonable assumptions,
such data involves risks and uncertainties and are subject to change based on various factors, including those discussed under the heading
“Risk Factors.”

<div align='center'>WHERE YOU CAN FIND MORE INFORMATION</div>

We
have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities being offered by
this prospectus. This prospectus does not contain all of the information in the registration statement and its exhibits. For further information
with respect to us and the securities offered by this prospectus, we refer you to the registration statement and its exhibits. Statements
contained in this prospectus as to the contents of any contract or any other document referred to are not necessarily complete, and in
each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these
statements is qualified in all respects by this reference.

You
can read our SEC filings, including the registration statement, over the Internet at the SEC’s website at www.sec.gov. You may also
request a copy of these filings, at no cost, by writing us at 11555 Sorrento Valley Road, Suite 203, San Diego, California 92121 or telephoning
us at (619) 941-0360.

We
are subject to the information and periodic reporting requirements of the Exchange Act, and we file periodic reports, proxy statements
and other information with the SEC. These periodic reports, proxy statements and other information are available at the website of the
SEC referred to